XML 20 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Galectin Science LLC - Additional Information (Detail) (USD $)
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 31, 2014
Sep. 30, 2014
Sep. 30, 2014
Schedule Of Investments In Joint Venture [Line Items]      
Initial capital contribution for research and development $ 400,000    
Fair value of research and development services 400,000    
Equity Method Investment, Ownership Percentage   50.00% 50.00%
Loss from equity method investment in Galectin Sciences, LLC   (53,000) (390,000)
Non-cash charge for in-process research and development     $ 200,000